Accessing hepatitis C direct acting antivirals among people living with hepatitis C

A qualitative study

Chronic hepatitis C viral (HCV) infection is a significant global public health concern. Fortunately, chronic hepatitis C is now curable in almost every infected person with direct-acting antivirals (DAAs), yet uptake of treatment remains low in Canada, particularly among people who inject drugs.

This qualitative study characterizes the perceptions and experiences of hepatitis C treatment among people who do and do not inject drugs in Toronto where access to treatment is not otherwise limited by the availability of treatment specialists and programs to support people who inject drugs.

We are grateful to the participants of the study for their time and contributions.

Access the full article and associated resources:

Please note that this report is NOT COMPLETE and is still in progress. Click below if you would like to continue.